By Monica Heger

This story was originally published Jan. 5.

Next-gen sequencing could find a new application in synthetic biology — as a sample-prep step to make DNA for gene synthesis. Scientists from the German company Febit are looking to spin out a new company that would commercialize a new method of DNA synthesis based on the approach, which they say could reduce the price of synthetic DNA by several fold.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.